Low levels of bile acids increase bacterial uptake in colonic biopsies from patients with collagenous colitis in remission

Alimentary Pharmacology and Therapeutics

Volumn 33, Issue 8, 2011, Pages 954-960

  Munch A ^a,c   Soderholm J D ^a   Ost A ^b   Carlsson, A H ^a   Magnusson, K E ^a   Strom M ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Medilab   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BUDESONIDE; CHENODEOXYCHOLIC ACID; DEOXYCHOLIC ACID;

ARTICLE; BACTERIAL TRANSLOCATION; CLINICAL ARTICLE; COLLAGENOUS COLITIS; COLON BIOPSY; COLON MUCOSA; COLONOSCOPY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOSCOPIC BIOPSY; ESCHERICHIA COLI K 12; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SHORT CIRCUIT CURRENT; SIGMOID;

ADULT; AGED; AGED, 80 AND OVER; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; BIOPSY; BUDESONIDE; CASE-CONTROL STUDIES; CHENODEOXYCHOLIC ACID; COLITIS, COLLAGENOUS; DEOXYCHOLIC ACID; ESCHERICHIA COLI K12; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED;

EID: 79952777720     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04611.x     Document Type: Article

References (33)

1. Olesen M, Eriksson S, Bohr J, et al. Microscopic colitis: a common diarrhoeal disease. An epidemiologic study in Örebro, Sweden, 1993-1998. Gut 2004; 53: 346-50. (Pubitemid 38241327)
2. Wickbom A, Nylin N, Eriksson S, et al. Stable incidence of collagenous colitis and lymphocytic colitis in Örebro, Sweden 1999-2008. Gut 2009; 58 (Suppl. II): A58.
3. Pardi DS, Loftus EV, Smyrk TC, et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut 2007; 56: 504-8. (Pubitemid 46580505)
4. Bohr J, Tysk C, Yang P, et al. Autoantibodies and immunoglobulins in collagenous colitis. Am J Gastroenterol 1992; 87: 780-3.
5. Freeman HJ,. Perinuclear autoneutrophil cytoplasmic antibodies in collagenous or lymphocytic colitis with or without celiac disease. Can J Gastroenterol 1997; 11: 417-20. (Pubitemid 27359086)
6. Bohr J, Nordfelth R, Järnerot G, et al. Yersinia species in collagenous colitis: a serologic study. Scand J Gastroenterol 2002; 37: 711-7.
7. Beaugerie L, Pardi DS,. Review article: drug-induced microscopic colitis-proposal for a scoring system and review of the literature. Aliment Pharmacol Ther 2005; 22: 277-84. (Pubitemid 41207456)
8. Ung KA, Gillberg R, Kilander A, et al. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut 2000; 46: 170-5. (Pubitemid 30305841)
9. Järnerot G, Tysk C, Bohr J, Eriksson S,. Collagenous colitis and fecal stream diversion. Gastroenterology 1995; 109: 449-55.
10. Baumgart DC, Carding SR,. Inflammatory bowel disease: cause and immunobiology. Lancet 2007; 369: 1627-40. (Pubitemid 46722636)
11. Münch A, Söderholm JD, Ost A, Ström M,. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment. Am J Gastroenterol 2009; 104: 679-85.
12. Chadwick VS, Gainella TS, Carlson GL, et al. Effects of molecular structure on bile acid-induced alterations in absorptive function, permeability and morphology in the perfused rabbit colon. J Lab Clin Med 1979; 94: 661-74. (Pubitemid 10210498)
13. Münch A, Ström M, Söderholm JD,. Dihydroxy bile acids increase mucosal permeability and bacterial uptake in human colon biopsies. Scand J Gastroenterol 2007; 42: 1-8.
14. Hjortswang H, Tysk C, Bohr J, et al. Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis 2009; 15: 1875-81.
15. Wallon C, Braaf Y, Wolving M, et al. Endoscopic biopsies in Ussing chamber evaluated for studies of macromolecular permeability in the human colon. Scand J Gastroenterol 2005; 40: 586-95. (Pubitemid 40676253)
16. Keita AV, Gullberg E, Ericson A, et al. Characterization of antigen and bacterial transport in the follicle-associated epithelium of human ileum. Lab Invest 2006; 86: 504-16.
17. Hamilton JP, Xie G, Raufman JP, et al. Human cecal bile acids: concentration and spectrum. Am J Physiol Gastrointest Liver Physiol 2007; 293: 256-63.
18. Rafter JJ, Branting C,. Bile acids-interaction with the intestinal mucosa. Eur J Cancer Prev 1991; 1 (Suppl. 2): 49-54.
19. Raimondi FR, Santoro P, Barone MV, et al. Bile acids modulate tight junction structure and barrier function of Caco-2 monolayer via EGFR activation. Am J Physiol Gastrointest Liver Physiol 2008; 294: 906-13.
20. Araki Y, Katoh T, Ogawa A, et al. Bile acids modulate transepithelial permeability via the generation of reactive oxygen species in the Caco-2 cell line. Free Radic Biol Med 2005; 39: 769-80. (Pubitemid 41149076)
21. Zareie M, Riff J, Donato K, et al. Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function. Cell Microbiol 2005; 7: 1782-97. (Pubitemid 41685271)
22. Otte JM, Podolsky DK,. Functional modulation of enterocytes by Gram-positive and Gram-negative microorganism. Am J Physiol Gastrointest Liver Physiol 2004; 286: 613-26.
23. Xavier RJ, Podolsky DK,. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-34. (Pubitemid 47123518)
24. Söderholm JD, Olaison G, Peterson KH, et al. Augmented tight junction permeability increase in non-inflamed ileal mucosa in Crohn's disease in response to sodium caprate in Ussing chambers-a distribution of perijunctional actin regulation? Gut 2002; 50: 307-13.
25. Sapp H, Ithamukkala S, Brien TP, et al. The terminal ileum is affected in patients with lymphocytic and collagenous colitis. Am J Surg Pathol 2002; 26: 1484-92. (Pubitemid 35239425)
26. Holmquist L, Andersson H, Rudic N, et al. Bile acids malabsorption in children and adolescents with chronic colitis. Scand J Gastroenterol 1986; 21: 87-92. (Pubitemid 16177468)
27. Tanaka M, Mazzoleni G, Riddell RH,. Distribution of collagenous colitis: utility of flexible sigmoidoscopy. Gut 1992; 33: 65-70.
28. Ejderhamn J, Rafter JJ, Strandvik B,. Faecal bile acid excretion in children with inflammatory bowel disease. Gut 1991; 32: 1346-51.
29. Kruis W, Kalek HD, Stellaard F, et al. Altered fecal bile acid pattern in patients with inflammatory bowel disease. Digestion 1986; 35: 189-98. (Pubitemid 17196480)
30. Chande N, MacDonald JK, McDonald JWD,. Interventions for treating microscopic colitis: a Cochrane inflammatory bowel disease and functional bowel disorders review group systemic review of randomized trials. Am J Gastroenterol 2009; 104: 235-41.
31. Boivin MA, Ye D, Kennedy JC, et al. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. Am J Physiol Gastrointest Liver Physiol 2007; 292: 590-8.
32. Bajor A, Kilander A, Gälman C, Rudling M, Ung KA,. Budesonide treatment is associated with increased bile acid absorption in collagenous colitis. Aliment Pharmacol Ther 2006; 24: 1643-9. (Pubitemid 44915212)
33. Miehlke S, Madisch A, Voss C, et al. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther 2005; 22: 1115-9. (Pubitemid 41779519)